David A. Siegel Corcept Therapeutics Inc Transaction History

Two Sigma Advisers, LP

$41.3 Billion
Q4 2024

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Two Sigma Advisers, LP holds 381,800 shares of CORT stock, worth $24.9 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

381,800

Previous 457,100 16.47%

Holding current value

$24.9 Million

Previous $21.1 Million 9.02%

% of portfolio

0.05%

Previous 0.05%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$44.66 - $60.85 $3.36 Million - $4.58 Million	-75,300 Reduced 16.47%	381,800 $19.2 Million
Q3 2024 Nov 14, 2024	SELL	$29.51 - $46.26 $1.71 Million - $2.68 Million	-57,900 Reduced 11.24%	457,100 $21.1 Million
Q2 2024 Aug 14, 2024	SELL	$22.21 - $34.48 $5.45 Million - $8.45 Million	-245,200 Reduced 32.25%	515,000 $16.7 Million
Q1 2024 May 15, 2024	BUY	$21.1 - $27.46 $4.72 Million - $6.15 Million	223,800 Added 41.72%	760,200 $19.1 Million
Q4 2023 Feb 14, 2024	BUY	$24.82 - $32.88 $3.14 Million - $4.17 Million	126,700 Added 30.93%	536,400 $17.4 Million
Q3 2023 Nov 14, 2023	BUY	$21.97 - $33.8 $2.16 Million - $3.32 Million	98,100 Added 31.48%	409,700 $11.2 Million
Q2 2023 Aug 14, 2023	BUY	$21.44 - $25.15 $6.68 Million - $7.84 Million	311,600 New	311,600 $6.93 Million
Q1 2021 May 17, 2021	SELL	$23.49 - $30.56 $345,303 - $449,232	-14,700 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$16.78 - $27.3 $380,906 - $619,710	-22,700 Reduced 60.7%	14,700 $385,000
Q3 2020 Nov 16, 2020	SELL	$12.46 - $19.98 $1.12 Million - $1.8 Million	-90,000 Reduced 70.64%	37,400 $651,000
Q2 2020 Aug 14, 2020	BUY	$11.0 - $18.26 $1 Million - $1.66 Million	91,000 Added 250.0%	127,400 $2.14 Million
Q1 2020 May 15, 2020	BUY	$10.11 - $14.04 $368,004 - $511,055	36,400 New	36,400 $433,000
Q4 2019 Feb 14, 2020	SELL	$12.06 - $16.96 $159,192 - $223,872	-13,200 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$10.41 - $14.66 $22,902 - $32,252	2,200 Added 20.0%	13,200 $187,000
Q2 2019 Aug 14, 2019	SELL	$9.78 - $12.76 $198,563 - $259,066	-20,303 Reduced 64.86%	11,000 $123,000
Q1 2019 May 15, 2019	BUY	$10.03 - $15.71 $60,179 - $94,260	6,000 Added 23.71%	31,303 $367,000
Q4 2018 Feb 14, 2019	BUY	$11.29 - $17.19 $285,670 - $434,958	25,303 New	25,303 $338,000
Q2 2018 Aug 14, 2018	SELL	$15.3 - $19.69 $1.97 Million - $2.54 Million	-128,894 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$14.59 - $25.5 $1.39 Million - $2.43 Million	-95,300 Reduced 42.51%	128,894 $2.12 Million
Q4 2017 Feb 14, 2018	SELL	$15.77 - $20.72 $1.07 Million - $1.41 Million	-68,100 Reduced 23.3%	224,194 $4.05 Million
Q3 2017 Nov 14, 2017	BUY	$12.3 - $19.3 $3.6 Million - $5.64 Million	292,294	292,294 $5.64 Million

Others Institutions Holding CORT

# of Institutions

403

Shares Held

84.3M

Call Options Held

1.04M

Put Options Held

1.33M

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $6.97B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account